Following the recently announced management buyout, supported by CBPE, we are delighted to announce the first of our significant strategic hires – the arrival of Alison Sampson, as Director of Project Management, to lead our International Project Management teams.
Alison is a known expert in the design and delivery of rare disease, paediatric and oncology clinical programmes. Amongst other things this expertise has led her to be a key note speaker at two recent annual meetings of the iCAN ‐ The International Children’s Advisory Network research advocacy group and at the World Orphan Drug Congress.
Alison joins us from senior positions in large and midsized CROs, where she focused on delivering across her therapeutic areas of excellence. She has also held operational roles in biotech and medical device companies.
With Alison’s recognised expertise added to Simbec-Orion’s existing pool of subject matter experts, we are delighted to be offering our clients an even stronger team to elegantly deliver on their clinical development needs.
For more information on how Simbec-Orion can support your rare disease, oncology or paediatric drug development needs please contact us at Info@SimbecOrionCRO.com